Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.98 EUR | 0.00% | -0.70% | -9.27% |
May. 07 | Intred, revenues grow by double-digit percent in first quarter | AN |
Apr. 19 | ITALY GROWTH WINNERS & LOSERS: Medica bullish; Plants in the red. | AN |
Valuation
Fiscal Period: December | 2021 | 2022 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|
Capitalization 1 | 299.6 | 229.3 | 158.4 | - | - |
Enterprise Value (EV) 1 | 294.2 | 240.8 | 186.8 | 183.9 | 176.4 |
P/E ratio | 34.8 x | 26.4 x | 23.5 x | 20.9 x | 17.9 x |
Yield | - | 0.48% | 0.81% | 0.87% | 0.96% |
Capitalization / Revenue | 7.4 x | 5.04 x | 2.74 x | 2.46 x | 2.22 x |
EV / Revenue | 7.27 x | 5.29 x | 3.23 x | 2.86 x | 2.47 x |
EV / EBITDA | 16.7 x | 12.1 x | 7.79 x | 6.78 x | 5.76 x |
EV / FCF | 14.3 x | -14.6 x | -58.4 x | 39 x | 18.7 x |
FCF Yield | 7.01% | -6.84% | -1.71% | 2.57% | 5.35% |
Price to Book | - | 4.78 x | 2.65 x | 2.42 x | 2.18 x |
Nbr of stocks (in thousands) | 15,851 | 15,865 | 15,873 | - | - |
Reference price 2 | 18.90 | 14.45 | 9.980 | 9.980 | 9.980 |
Announcement Date | 3/28/22 | 3/27/23 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2020 | 2021 | 2022 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Net sales 1 | - | 40.46 | 45.52 | 57.88 | 64.35 | 71.35 |
EBITDA 1 | - | 17.6 | 19.9 | 23.97 | 27.1 | 30.63 |
EBIT 1 | - | - | 12.16 | 11.27 | 12.97 | 15.3 |
Operating Margin | - | - | 26.72% | 19.46% | 20.15% | 21.44% |
Earnings before Tax (EBT) 1 | 8.181 | - | 12.18 | 10 | 11.65 | 14.65 |
Net income 1 | 6.111 | 8.62 | 8.675 | 7 | 8.117 | 9.85 |
Net margin | - | 21.31% | 19.06% | 12.09% | 12.61% | 13.81% |
EPS 2 | - | 0.5439 | 0.5468 | 0.4240 | 0.4785 | 0.5580 |
Free Cash Flow 1 | - | 20.63 | -16.48 | -3.2 | 4.717 | 9.433 |
FCF margin | - | 51% | -36.2% | -5.53% | 7.33% | 13.22% |
FCF Conversion (EBITDA) | - | 117.23% | - | - | 17.4% | 30.79% |
FCF Conversion (Net income) | - | 239.34% | - | - | 58.11% | 95.77% |
Dividend per Share 2 | - | - | 0.0700 | 0.0810 | 0.0870 | 0.0960 |
Announcement Date | 7/22/21 | 3/28/22 | 3/27/23 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2022 S1 | 2022 S2 | 2023 S1 |
---|---|---|---|
Net sales 1 | 23.35 | 22.17 | 24.7 |
EBITDA | - | - | - |
EBIT | - | - | - |
Operating Margin | - | - | - |
Earnings before Tax (EBT) | - | 6.032 | - |
Net income 1 | 4.267 | 4.408 | 3.901 |
Net margin | 18.28% | 19.88% | 15.79% |
EPS | - | - | - |
Dividend per Share | - | - | - |
Announcement Date | 9/30/22 | 3/27/23 | 9/27/23 |
Balance Sheet Analysis
Fiscal Period: December | 2020 | 2021 | 2022 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | 11.5 | 28.4 | 25.4 | 18 |
Net Cash position 1 | - | 5.41 | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | 0.5795 x | 1.183 x | 0.9387 x | 0.5864 x |
Free Cash Flow 1 | - | 20.6 | -16.5 | -3.2 | 4.72 | 9.43 |
ROE (net income / shareholders' equity) | - | - | 19.7% | 11.3% | 11.5% | 12.1% |
ROA (Net income/ Total Assets) | - | - | 8.19% | 4.9% | 5.2% | 5.5% |
Assets 1 | - | - | 105.9 | 142.9 | 156.1 | 179.1 |
Book Value Per Share 2 | - | - | 3.030 | 3.770 | 4.130 | 4.570 |
Cash Flow per Share | - | - | - | - | - | - |
Capex 1 | - | - | 39.3 | 26.6 | 18.7 | 17 |
Capex / Sales | - | - | 86.43% | 45.92% | 29.01% | 23.78% |
Announcement Date | 7/22/21 | 3/28/22 | 3/27/23 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-9.27% | 171M | |
+13.73% | 206B | |
+7.40% | 170B | |
+1.70% | 118B | |
-9.05% | 85.74B | |
+18.45% | 71.41B | |
+6.73% | 61.6B | |
-6.19% | 50.57B | |
-30.08% | 40.06B | |
-17.52% | 39.07B |
- Stock Market
- Equities
- ITD Stock
- Financials Intred S.p.A.